Technical Analysis for KRYS - Krystal Biotech, Inc.

Grade Last Price % Change Price Change
C 168.53 -2.57% -4.45
KRYS closed down 2.57 percent on Monday, March 18, 2024, on approximately normal volume.
6 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down

Date Alert Name Type % Chg
MACD Bearish Signal Line Cross Bearish 0.00%
Multiple of Ten Bearish Other 0.00%
Wide Bands Range Expansion 0.00%
Pocket Pivot Bullish Swing Setup -2.57%
NR7 Range Contraction -2.57%
Multiple of Ten Bullish Other -2.57%
Inside Day Range Contraction -2.57%
Wide Bands Range Expansion -2.57%
Multiple of Ten Bullish Other -1.93%
Wide Bands Range Expansion -1.93%

   Recent Intraday Alerts

Alert Time
Down 3% about 18 hours ago
Fell Below Previous Day's Low about 18 hours ago
Down 2 % about 18 hours ago
Down 1% about 18 hours ago
Fell Below 10 DMA about 18 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Krystal Biotech, Inc. Description

Krystal Biotech, Inc. gene therapy company. The Company is engaged in developing and commercializing novel treatments for patients suffering from dermatological diseases. The Company has developed a Skin TARgeted Delivery platform, or STAR-D platform, that consists of a patent pending engineered viral vector based on herpes simplex virus 1, or HSV-1, and skin-optimized gene transfer technology, to develop off-the-shelf treatments for dermatological diseases. The Company’s products include KB103 and KB104.The Compnay's KB103 is in preclinical development to treat dystrophic epidermolysis bullosa, or DEB, a rare and severe genetic disease. The Compnay's KB104 is to treat Netherton Syndrome, a severe form of ichthyosis, which is a family of genetic skin disorders associated with thickened scaly skin and characterized by chronic skin inflammation, itchiness, dehydration and stunted growth.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Clinical Medicine Clinical Development Rare Diseases Inflammation Gene Therapy Genetic Diseases Genodermatoses Herpes Epidermolysis Bullosa Dehydration Herpes Simplex Netherton Syndrome Herpes Simplex Virus Skin Inflammation Dermatological Diseases Ichthyosis Itchiness

Is KRYS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 189.97
52 Week Low 72.18
Average Volume 427,594
200-Day Moving Average 121.73
50-Day Moving Average 134.70
20-Day Moving Average 157.45
10-Day Moving Average 172.86
Average True Range 9.32
RSI (14) 61.09
ADX 44.11
+DI 30.01
-DI 15.29
Chandelier Exit (Long, 3 ATRs) 162.02
Chandelier Exit (Short, 3 ATRs) 135.45
Upper Bollinger Bands 205.51
Lower Bollinger Band 109.39
Percent B (%b) 0.62
BandWidth 61.05
MACD Line 13.30
MACD Signal Line 13.49
MACD Histogram -0.1955
Fundamentals Value
Market Cap 4.75 Billion
Num Shares 28.2 Million
EPS -1.17
Price-to-Earnings (P/E) Ratio -144.04
Price-to-Sales 367.12
Price-to-Book 4.16
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 178.67
Resistance 3 (R3) 178.81 175.56 176.98
Resistance 2 (R2) 175.56 172.98 175.50 176.42
Resistance 1 (R1) 172.05 171.39 170.43 171.91 175.85
Pivot Point 168.80 168.80 167.99 168.74 168.80
Support 1 (S1) 165.29 166.22 163.67 165.15 161.21
Support 2 (S2) 162.04 164.63 161.98 160.64
Support 3 (S3) 158.53 162.04 160.08
Support 4 (S4) 158.39